... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 SR-cGVHD Imatinib mesylate Atorvastatin calcium Allogeneic hematopoietic stem cell transplantation Combination therapy Allogeneic...

...Guan-hua Hu; Xiao-hui Zhang; Kai-yan Liu; Lan-ping Xu; Yu Wang; Yi-fei Cheng; Xiao-jun Huang Introduction: The role of haploidentical allogeneic hematopoietic stem cell transplantation (haplo-HSCT) in pediatric patients with relapsed or refractory (R/R) ETV6/RUNX1 -positive acute lymphoblastic...

.... The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Acute myeloid leukemia Allogeneic hematopoietic stem cell transplantation Donor lymphocyte...

... in a profound drug-drug interaction that is further complicated by the use of azole antifungals. Case Presentations: We describe three strategies, in 4 patient cases, for the initiation of NIM/r in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients on tacrolimus at the time of diagnosis...

... allogeneic hematopoietic stem cell transplantation (allo-HSCT) at the Seventh Medical Center of PLA General Hospital between January 2008 and June 2017. Methods: Patients were categorized into the Bu (Bu + Flu + Cy + ATG-F regimen) and control (Flu + Cy + ATG-F) groups, with a median follow-up time after...

...Israel Henig; Dana Yehudai-Ofir; Yaniv Zohar; Tsila Zuckerman Pure red cell aplasia (PRCA) can potentially occur after allogeneic hematopoietic stem cell transplantation (allo-HSCT) if recipient and donor ABO blood groups are mismatched, with the recipient having isoagglutinins against the donor...

..., instructions or products referred to in the content or advertisements. T-cell prolymphocytic leukemia (T-PLL) Alemtuzumab Allogeneic hematopoietic stem cell transplantation Donor lymphocyte infusion T-cell prolymphocytic leukemia (T-PLL) is a rare and mostly aggressive lymphoid neoplasm...

...Peng Ke; Xiebing Bao; Jihao Zhou; Qian Zhu; Juan Zhuang; Xiaohui Hu; Yuejun Liu; Depei Wu; Shengli Xue; Xinyou Zhang; Xiao Ma Central nervous system complications (CNSCs) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are common and may be a significant source of morbidity...

... cell source and dose on allogeneic hematopoietic stem cell transplantation (alloHSCT) in AA. Results: A total of 267 patients were included in this analysis. The BM-treated group showed an association with low incidence of any-grade acute graft versus host disease (GvHD) ( p < 0.001). A higher stem...

... patients treated with chemotherapy only. Allogeneic hematopoietic stem cell transplantation attenuated the negative impact of high PLT counts on the survival of intermediate-risk patients. Furthermore, univariate and multivariate analyses demonstrated that PLT count at diagnosis was an independent...

...Yasuyuki Inoue; Manabu Matsunawa; Fumiaki Sano; Ikuo Miura The prognosis for patients who experience hemostatic complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is poor. However, no report has investigated disseminated intravascular coagulation (DIC) caused...

... the pre-engraftment phase after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Consecutive patients who underwent non-T-cell-depleted allo-HSCT at the Peking University Institute of Hematology from January 1 to December 31, 2016 were enrolled ( n = 646). Ninety-nine patients were found...

... etiology. Here, we report on a 56-year-old female with multiple myeloma who presented with undulating fever, fluctuating abdominal symptoms, and a distended abdomen 5 months after allogeneic hematopoietic stem cell transplantation (HSCT). Abdominal X-ray and CT scan documented PI with gas accumulation both...

... such as Pneumocystis jirovecii constitute life-threatening risks for patients after allogeneic hematopoietic stem cell transplantation. Trimethoprim/sulfamethoxazole (TMP-SMX) has been well established for post-transplant toxoplasmosis and pneumocystis prophylaxis, but treatment may be limited due to toxicity. We...

...Hui Liu; Yinkui Chen; Li Xuan; Xiuli Wu; Yu Zhang; Zhiping Fan; Fen Huang; Xian Zhang; Qianli Jiang; Jing Sun; Qifa Liu Background: Graft-versus-host disease (GVHD) remains a main complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Human leukocyte antigen G (HLA-G...

..., he achieved a complete cytogenetic response (CCyR). Although the CCyR persisted in his bone marrow, he developed an isolated CML blast crisis in his central nervous system (CNS) after 29 months of therapy. He underwent allogeneic hematopoietic stem cell transplantation (HSCT) following combination...

...Xin-Chuan Chen; Ting Liu; Jian-Jun Li; Chuan He; Weng-Tong Meng; Rui Huang BK virus-associated hemorrhagic cystitis (BKV-HC) is a severe complication after allogeneic hematopoietic stem cell transplantation. So far, no specific antiviral drug with proven efficacy has been approved for treating BKV...

... hematopoietic stem cell transplantation The treatment of chronic myeloid leukemia (CML) underwent dramatic changes in recent years. From the 1980s to 2000, allogeneic hematopoietic stem cell transplantation (HSCT) was the treatment of choice for younger patients in first chronic phase (CP) if an HLA...

... of a skin relapse on day 398 after allogeneic hematopoietic stem cell transplantation (allo-HSCT). To induce a graft-versus-adult T-cell leukemia/lymphoma effect, we discontinued methylprednisolone and tacrolimus. About a month after the discontinuation, he developed grade II acute graft-versus-host disease...

... lymphoblastic leukemia (Ph+ ALL), relapse remains common, even among allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Recently, preclinical and preliminary clinical studies suggested a potential therapeutic role of nilotinib, a second-generation TKI, in Ph+ ALL, including patients who...